Franco Merckling
Directeur Général chez Kenta Biotech AG
Profil
Franco Merckling is currently the Chief Executive Officer at Kenta Biotech AG since 2011.
He previously worked as the Managing Director at Eisai Srl and as a Member-Management Board at SANOCHEMIA Pharmazeutika GmbH.
Dr. Merckling holds a doctorate degree from the University of Zurich.
Postes actifs de Franco Merckling
| Sociétés | Poste | Début |
|---|---|---|
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Directeur Général | 01/09/2011 |
Anciens postes connus de Franco Merckling
| Sociétés | Poste | Fin |
|---|---|---|
| SANOCHEMIA PHARMAZEUTIKA AG | Directeur Général | 30/09/2016 |
Eisai Srl
 Eisai Srl Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Srl is an Italian company that manufactures and supplies pharmaceutical products. The company is based in Milan, Italy. | President | - |
Formation de Franco Merckling
| University of Zurich | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
SANOCHEMIA Pharmazeutika GmbH
 SANOCHEMIA Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria. | Health Technology |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
Eisai Srl
Eisai Srl Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Srl is an Italian company that manufactures and supplies pharmaceutical products. The company is based in Milan, Italy. | Health Technology |
